Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings

Collarino, A.; Koster, E.J. de; Olmos, R.A.V.; Geus-Oei, L.F. de; Arias-Bouda, L.M.P. (2018)

Article / Letter to editor

• Locally advanced BC
• NAC response
• Nuclear breast imaging
• Tc-99m-sestamibi
• Therapy monitoring

• All authors: Collarino, A.; Koster, E.J. de; Olmos, R.A.V.; Geus-Oei, L.F. de; Arias-Bouda, L.M.P.
• Date: 2018-02-28
• Journal: Clinical Breast Cancer
• Volume: 18
• Issue: 1
• Pages: 9 - 18
• DOI: doi:10.1016/j.clbc.2017.06.008